Publications by authors named "Harry Alcorn"

Claim this Profile
P
Pharmacokinetics and Pharmacodynamics of a Novel Formulation of Furosemide Administered as a Single Subcutaneous Injection.
Harry Alcorn, John F Mohr, James E Udelson, Barbara W Cornelius, Michael DiBattista

Clin Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Gepotidacin in Renal Impairment.
Mohammad Hossain, Courtney Tiffany, Aparna Raychaudhuri, Dung Nguyen, Guoying Tai, Harry Alcorn

Clin Pharmacol Drug Dev· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban in Chronic Hemodialysis Patients.
Heather Muster, Harry Alcorn

Am J Nephrol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Intravenous Delafloxacin in Patients With End-Stage Renal Disease.
Randall Hoover, Harry Alcorn, Laura Lawrence, Susan K Paulson, Megan Quintas

J Clin Pharmacol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacokinetics of Sulfobutylether-β-Cyclodextrin in Patients With Varying Degrees of Renal Impairment.
Randall K Hoover, Harry Alcorn, Laura Lawrence, Susan K Paulson, Megan Quintas

J Clin Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function.
Randall K Hoover, Harry Alcorn, Laura Lawrence, Susan K Paulson, Megan Quintas

J Clin Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics.
Robert W Townsend, Shahzad Akhtar, Harry Alcorn, Jolene K Berg, Donna L Kowalski

Eur J Clin Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special Populations in Clinical Pharmacology Studies: Evolving Challenges.
William B Smith, Harry Alcorn

Ther Innov Regul Sci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment.
Tushar Garimella, Reena Wang, Wen-Lin Luo, Carey Hwang, Diane Sherman, Harry Alcorn

Antivir Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis.
Anthony J Bleyer, David Wright, Harry Alcorn

Clin Nephrol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus.
Amale Hawi, Harry Alcorn, Jolene Berg, Carey Hines, Howard Hait

BMC Nephrol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, pharmacodynamics, safety, and tolerability of nebulized sodium nitrite (AIR001) following repeat-dose inhalation in healthy subjects.
Peter J Rix, Andrew Vick, Neil J Attkins, Geoffrey E Barker, Adrian W Bott, Harry Alcorn

Clin Pharmacokinet· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of vilazodone in patients with mild or moderate renal impairment.
Ramesh Boinpally, Harry Alcorn, Marijke H Adams, James Longstreth, John Edwards

Clin Drug Investig· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics of PF-734200, a DPP-IV inhibitor, in subjects with renal insufficiency.
Haiqing Dai, Susan L Johnson, Steven G Terra, Thomas C Marbury, William B Smith, Harry Alcorn

Br J Clin Pharmacol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical and biological variation in measures of anemia and iron status in patients treated with maintenance hemodialysis.
David B Van Wyck, Harry Alcorn, Resmi Gupta

Am J Kidney Dis· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of association with candidate genes for diabetic nephropathy in a Mexican American population.
Sulgi Kim, Hanna E Abboud, Madeleine V Pahl, John Tayek, Susan Snyder, Harry Alcorn

Clin J Am Soc Nephrol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacokinetics evaluation of a new, low-volume, oral sulfate colon cleansing preparation in patients with renal or hepatic impairment and healthy volunteers.
Russell W Pelham, Harry Alcorn, Mark vB Cleveland

J Clin Pharmacol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
Xiao-Jian Zhou, Thomas C Marbury, Harry W Alcorn, William B Smith, Gloria Dubuc Patrick

Antimicrob Agents Chemother· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study.
Suzanne K Swan, Harry Alcorn, Anthony Rodgers, Carolyn M Hustad, Karen E Ramsey

J Clin Pharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction.
Kamyar Kalantar-Zadeh, Ryan D Kilpatrick, Noriko Kuwae, Charles J McAllister, Harry Alcorn

Nephrol Dial Transplant· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of etoricoxib in patients with renal impairment.
Nancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, Walter F Kline, Eric J Woolf, Harry Alcorn

J Clin Pharmacol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
Henry Shinefield, Steven Black, Ali Fattom, Gary Horwith, Scott Rasgon, Harry Alcorn

N Engl J Med· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis